´╗┐
 Return to CG106 Overview

Barrett's oesophagus: ablative therapy [CG106]

Measuring the use of this guidance

Recommendation: 1.1.2

Consider offering endoscopic therapy as an alternative to oesophagectomy to people with high-grade dysplasia and intramucosal cancer (T1a), taking into account individual patient preferences and general health. Endoscopic therapy is particularly suitable for patients who are considered unsuitable for surgery or who do not wish to undergo oesophagectomy.

What was measured: Proportion of people with high-grade dysplasia who had a planned endoscopic therapy.
Data collection end: March 2018
69.6%
Area covered: National
Source: National Oesophago-Gastric cancer Audit Report


Recommendation: 1.3.1

Offer F-18 FDG PET-CT to people with oesophageal and gastro-oesophageal junctional tumours that are suitable for radical treatment (except for T1a tumours).

What was measured: Proportion of people with oesophago-gastric cancer, who had curative treatment, that had a PET-CT scan.
Data collection end: March 2018
78.7%
Area covered: National
Source: National Oesophago-Gastric cancer Audit Report



 Return to CG106 Overview